These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. In silico drug re-purposing against African sleeping sickness using GlcNAc-PI de-N-acetylase as an experimental target. Rashmi M; Swati D Comput Biol Chem; 2015 Dec; 59 Pt A():87-94. PubMed ID: 26476127 [TBL] [Abstract][Full Text] [Related]
25. Closing in on a new treatment for sleeping sickness. Derbyshire ER; Clardy J Elife; 2013 Jul; 2():e01042. PubMed ID: 23853715 [TBL] [Abstract][Full Text] [Related]
26. The susceptibility of trypanosomatid pathogens to PI3/mTOR kinase inhibitors affords a new opportunity for drug repurposing. Diaz-Gonzalez R; Kuhlmann FM; Galan-Rodriguez C; Madeira da Silva L; Saldivia M; Karver CE; Rodriguez A; Beverley SM; Navarro M; Pollastri MP PLoS Negl Trop Dis; 2011 Aug; 5(8):e1297. PubMed ID: 21886855 [TBL] [Abstract][Full Text] [Related]
27. Design and synthesis of Trypanosoma brucei active 1-alkyloxy and 1-benzyloxyadamantano 2-guanylhydrazones. Papanastasiou I; Tsotinis A; Zoidis G; Kolocouris N; Prathalingam SR; Kelly JM ChemMedChem; 2009 Jul; 4(7):1059-62. PubMed ID: 19422003 [TBL] [Abstract][Full Text] [Related]
28. High-throughput whole genome analysis provides insight into how the major drugs against African sleeping sickness operate. Rudenko G Pathog Glob Health; 2012 May; 106(2):79. PubMed ID: 22943541 [No Abstract] [Full Text] [Related]
29. C1'-Branched acyclic nucleoside phosphonates mimicking adenosine monophosphate: Potent inhibitors of Trypanosoma brucei adenine phosphoribosyltransferase. Kalčic F; Frydrych J; Doleželová E; Slapničková M; Pachl P; Slavětínská LP; Dračínský M; Hocková D; Zíková A; Janeba Z Eur J Med Chem; 2021 Dec; 225():113798. PubMed ID: 34482272 [TBL] [Abstract][Full Text] [Related]
30. QSAR analysis for 6-arylpyrazine-2-carboxamides as Trypanosoma brucei inhibitors. Masand VH; El-Sayed NN; Mahajan DT; Rastija V SAR QSAR Environ Res; 2017 Feb; 28(2):165-177. PubMed ID: 28235390 [TBL] [Abstract][Full Text] [Related]
31. Andrographolide induces oxidative stress-dependent cell death in unicellular protozoan parasite Trypanosoma brucei. Banerjee M; Parai D; Dhar P; Roy M; Barik R; Chattopadhyay S; Mukherjee SK Acta Trop; 2017 Dec; 176():58-67. PubMed ID: 28739368 [TBL] [Abstract][Full Text] [Related]
32. Solid phase synthesis and antiprotozoal evaluation of di- and trisubstituted 5'-carboxamidoadenosine analogues. Rodenko B; Detz RJ; Pinas VA; Lambertucci C; Brun R; Wanner MJ; Koomen GJ Bioorg Med Chem; 2006 Mar; 14(5):1618-29. PubMed ID: 16249090 [TBL] [Abstract][Full Text] [Related]
33. Independence from Kinetoplast DNA maintenance and expression is associated with multidrug resistance in Trypanosoma brucei in vitro. Gould MK; Schnaufer A Antimicrob Agents Chemother; 2014 May; 58(5):2925-8. PubMed ID: 24550326 [TBL] [Abstract][Full Text] [Related]
35. Metal-chelating agents against viruses and parasites. Giannakopoulou E; Pardali V; Zoidis G Future Med Chem; 2018 Jun; 10(11):1283-1285. PubMed ID: 29719970 [No Abstract] [Full Text] [Related]
36. Novel 2H-isoquinolin-3-ones as antiplasmodial falcipain-2 inhibitors. Micale N; Ettari R; Schirmeister T; Evers A; Gelhaus C; Leippe M; Zappalà M; Grasso S Bioorg Med Chem; 2009 Sep; 17(18):6505-11. PubMed ID: 19709887 [TBL] [Abstract][Full Text] [Related]
37. In Vitro Antitrypanosomal Activity of the Secondary Metabolites from the Mutant Strain IU-3 of the Insect Pathogenic Fungus Ophiocordyceps coccidiicola NBRC 100683. Ganaha M; Yoshii K; Ōtsuki Y; Iguchi M; Okamoto Y; Iseki K; Ban S; Ishiyama A; Hokari R; Iwatsuki M; Otoguro K; Ōmura S; Hashimoto T; Noji M; Umeyama A Chem Pharm Bull (Tokyo); 2016; 64(7):988-90. PubMed ID: 27373660 [TBL] [Abstract][Full Text] [Related]
38. Role of calcium in trypanocidal drug action. Clarkson AB; Amole BO Science; 1982 Jun; 216(4552):1321-3. PubMed ID: 6805075 [TBL] [Abstract][Full Text] [Related]